Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: Protocol for randomised controlled home trial to evaluate the Suspend before low function

BMJ Open

Volumn 6, Issue 4, 2016, Pages

  Abraham, M B ^a,b   Nicholas, J A ^c   Ly, T T ^a,b,c   Roby, H C ^c   Paramalingam, N ^a,c   Fairchild, J ^d   King, B R ^e   Ambler, G R ^f   Cameron, F ^g   Davis, E A ^a,b,c   Jones, T W ^a,b,c  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e JOHN HUNTER CHILDREN S HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HORMONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE METER; CHILD; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; ELECTRICAL EQUIPMENT; GENERAL MEDICAL DEVICE; GLUCOSE SENSOR; HOME CARE; HOME SAFETY; HORMONE RESPONSE; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; INTERVENTION STUDY; LOW GLUCOSE SUSPEND SYSTEM; MULTICENTER STUDY; PARALLEL DESIGN; PATIENT SAFETY; PREDICTIVE VALUE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SENSOR AUGMENTED PUMP THERAPY; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; KETOACIDOSIS; METABOLISM; OUTCOME ASSESSMENT; PHYSIOLOGIC MONITORING; PROCEDURES; SAFETY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HORMONES; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; KETOSIS; MONITORING, PHYSIOLOGIC; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SAFETY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84969703225     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-011589     Document Type: Article

References (22)

1. Barnard K, Thomas S, Royle P, et al. Fear of hypoglycaemia in parents of young children with Type 1 diabetes: a systematic review. BMC Pediatr 2010;10:50.
2. Choudhary P, Shin J, Wang Y, et al. Insulin pump therapy with automated insulin suspension in response to hypoglycaemia: reduction in nocturnal hypoglycaemia in those at greatest risk. Diabetes Care 2011;34:2023-5.
3. Garg S, Brazg RL, Bailey TS, et al. Reduction in duration of hypoglycaemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther 2012;14:205-9.
4. Ly TT, Nicholas JA, Retterath A, et al Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycaemia in patients with Type 1 diabetes: a randomized clinical trial. JAMA 2013;310:1240-7.
5. Ly TT, Nicholas JA, Retterath A, et al Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy. Diabetes Care 2012;35:1462-5.
6. Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin-pump interruption for reduction of hypoglycaemia. N Engl J Med 2013;369:224-32.
7. Ly TT, Gallego PH, Davis EA, et al. Impaired awareness of hypoglycaemia in a population-based sample of children and adolescents with Type 1 diabetes. Diabetes Care 2009;32:1802-6.
8. Cranston I, Lomas J, Maran A, et al. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994;344:283-7.
9. Buckingham B, Chase HP, Dassau E, et al Prevention of nocturnal hypoglycaemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care 2010;33:1013-17.
10. Buckingham B, Cobry E, Clinton P, et al. Preventing hypoglycaemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther 2009; 11:93-7.
11. Buckingham BA, Cameron F, Calhoun P, et al. Outpatient safety assessment of an in-home predictive low-glucose suspend system with Type 1 diabetes subjects at elevated risk of nocturnal hypoglycaemia. Diabetes Technol Ther 2013;15:622-7.
12. Maahs DM, Calhoun P, Buckingham BA, et al. A randomized trial of a home system to reduce nocturnal hypoglycaemia in type 1 diabetes. Diabetes Care 2014;37:1885-91.
13. Abraham M, de Bock M, Davey R, et al Performance of a predictive algorithm in sensor-augmented pump therapy in the prevention of hypoglycaemia. Int J Pediatr Endocrinol 2015;2015:1.
14. Danne T, Tsioli C, Kordonouri O, et al. The PILGRIM Study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise. Diabetes Technol Ther 2014;16:338-47.
15. Choudhary P, Olsen BS, Conget I, et al. Hypoglycaemia prevention and user acceptance of an insulin pump system with predictive low glucose management. Diabetes Technol Ther Published Online First: 23 Feb 2016. doi:10.1089/dia.2015.0324.
16. Clarke WL, Cox DJ, Gonder-Frederick LA, et al. Reduced awareness of hypoglycaemia in adults with IDDM. A prospective study of hypoglycaemic frequency and associated symptoms. Diabetes care 1995;18:517-22.
17. Varni JW, Curtis BH, Abetz LN, et al. Content validity of the PedsQL 3.2 Diabetes Module in newly diagnosed patients with Type 1 diabetes mellitus ages 8-45. Qual Life Res 2013;22:2169-81.
18. Cox DJ, Irvine A, Gonder-Frederick L, et al. Fear of hypoglycaemia: quantification, validation, and utilization. Diabetes Care 1987;10:617-21.
19. Ly TT, Maahs DM, Rewers A, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycaemia in children and adolescents with diabetes. Pediatric Diabetes 2014;15 20):180-92.
20. Saghaei M. An overview of randomization and minimization programs for randomized clinical trials. J Med Signals Sens 2011;1:55-61.
21. Altman DG, Bland JM Treatment allocation by minimisation. BMJ 2005;330:843.
22. Brink S, Laffel L, Likitmaskul S, et al. Sick day management in children and adolescents with diabetes. Pediatric Diabetes 2009;10 (Suppl 12):146-53.